These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 21791482)

  • 21. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
    Singh RS; Wang HH
    Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
    Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
    Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
    Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
    Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the malignancy risk for atypia of undetermined significance? Three years' experience at a university hospital in Turkey.
    Gocun PU; Karakus E; Bulutay P; Akturk M; Akin M; Poyraz A
    Cancer Cytopathol; 2014 Aug; 122(8):604-10. PubMed ID: 24890894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
    Wu HH; Rose C; Elsheikh TM
    Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
    Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy.
    Kuru B; Atmaca A; Kefeli M
    Diagn Cytopathol; 2016 May; 44(5):394-8. PubMed ID: 26917413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Lim JXY; Nga ME; Chan DKH; Tan WB; Parameswaran R; Ngiam KY
    Thyroid; 2018 Apr; 28(4):511-521. PubMed ID: 29596039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases.
    Smith M; Pantanowitz L; Khalbuss WE; Benkovich VA; Monaco SE
    Acta Cytol; 2013; 57(4):341-8. PubMed ID: 23859872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
    Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
    Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: Experience of a Tertiary Care Referral Center.
    Heider A; Arnold S; Jing X
    Arch Pathol Lab Med; 2020 Apr; 144(4):473-477. PubMed ID: 31403334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
    Seagrove-Guffey MA; Hatic H; Peng H; Bates KC; Odugbesan AO
    Cancer Cytopathol; 2018 Oct; 126(10):881-888. PubMed ID: 30335212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.